Description
Inside the FDA: Strategy & Guidance with Dr. Adam Saltman
February 24 (Munich), 25 (Ochsenhausen, near Ulm), 26 (Berlin), 2026
Please note that this event will be held across three different locations on three separate dates. Kindly choose the option that best fits your schedule.
Join us for an exclusive session with Dr. Adam Saltman, offering valuable insights into FDA strategy and guidance for the medical device community. In partnership with Virtonomy GmbH, Paconsult GmbH, and Kalms Consulting GmbH, this interactive event will provide practical recommendations and real-world examples to help you navigate FDA regulatory challenges effectively.
What to Expect:
- Expert Presentation by Dr. Adam Saltman, who worked for 12 years as a Medical Officer at the U.S. FDA.
- Target Therapeutic Area: All therapeutic areas
- Strategies for managing increased requirements with limited resources
- Dos and don’ts when working with the FDA
- Future direction of the FDA
- Case studies
- Networking Lunch: Enjoy a catered lunch sponsored by NAMSA.
- Interactive Q&A Session: Get your questions answered by an FDA expert.
Event Details:
- Duration: 3 hours (from 11AM to 2PM)
- Cost: free
- Dates & Locations (choose one that suits your preferences and register below):
- February 24 – Munich, hosted by Virtonomy GmbH (Paul-Heyse-Straße 6, 80336 München)
- February 25 – Ochsenhausen (near Ulm), hosted by Paconsult GmbH (Kolpingstrasse 14, 88416 Ochsenhausen)
- February 26 – Berlin, hosted by Kalms Consulting GmbH (Rheinstraße 45-46, 12161 Berlin)
Who Should Attend:
Medical device professionals, regulatory specialists, and anyone seeking strategic guidance for FDA interactions.
Speaker
Adam E. Saltman, MD, PhD Chief Medical Officer, NAMSA
As a Board-Certified Cardiothoracic Surgeon, Dr. Saltman has more than 25 years’ experience in the management of complex patients with multiple comorbidities. He also worked for 12 years as a Medical Officer at the U.S. FDA Center for Devices and Radiological Health, where he gained a deep understanding of the requirements for successful medical device introductions, as well as quality systems, compliance and benefit-risk evaluations. Before joining NAMSA, Dr. Saltman earned industry experience as the first Chief Medical and Regulatory Officer for two medical device organizations, during which he successfully brought three AI-powered devices through R&D, clinical validation, regulatory approval and market introduction.
